3.52
Adverum Biotechnologies Inc (ADVM) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | 1.00 | - |
|
3.39%
49.85
|
48.22 | 42.62 | 35.44 | 32.90 |
Depreciation and Amortization |
21.67%
0.535
|
0.683 | 0.81 | 0.89 | 0.956 |
Operating Income/Loss |
3.39%
-49.85
|
-48.22 | -42.62 | -34.44 | -32.90 |
Income/Loss From Continuing Operations Before Tax |
4.62%
-49.19
|
-47.02 | -60.53 | -27.13 | -18.48 |
Income/Loss From Continuing Operations After Tax |
4.62%
-49.19
|
-47.02 | -40.93 | -32.35 | -30.50 |
|
4.62%
-49.19
|
-47.02 | -40.93 | -32.35 | -30.50 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.34%
21.01
|
20.94 | 0.374 | 20.88 | 20.85 |
Diluted Average Shares |
0.34%
21.01
|
20.94 | 0.374 | 20.88 | 20.85 |
Basic Earnings Per Share |
4.00%
-2.34
|
-2.25 | -1.98 | -1.55 | -1.46 |
Diluted Earnings Per Share |
4.00%
-2.34
|
-2.25 | -1.98 | -1.55 | -1.46 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):